Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Journal of Clinical Virology Plus
|
September 1, 2023
SARS-CoV-2 antibody response duration and neutralization following natural infection
Christopher W Dukes, Renata Am Rossetti, Jonathan A Hensel, et al.
Vaccines
|
January 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
Christopher W Dukes, Marine Potez, Jeffrey Lancet, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease
Mariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
Nanoparticles use magnetoelectricity to target and eradicate cancer cells
John Michael Bryant, Emmanuel Stimphil, Victoria Andre, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2025
Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models
John Michael Bryant, Max Shotbolt, Emmanuel Stimphil, et al.
Immunity
|
April 16, 2020
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling
Eslam Mohamed, Rosa A Sierra, Jimena Trillo-Tinoco, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma
Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
Frontiers in Immunology
|
December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
Lilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Journal of Clinical Virology Plus
|
September 1, 2023
SARS-CoV-2 antibody response duration and neutralization following natural infection
Christopher W Dukes, Renata Am Rossetti, Jonathan A Hensel, et al.
Vaccines
|
January 22, 2024
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
Christopher W Dukes, Marine Potez, Jeffrey Lancet, et al.
Biorxiv : the Preprint Server for Biology
|
January 8, 2024
Branched-chain keto acids promote an immune-suppressive and neurodegenerative microenvironment in leptomeningeal disease
Mariam Lotfy Khaled, Yuan Ren, Ronak Kundalia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 10, 2022
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
MacLean S Hall, John E Mullinax, Cheryl A Cox, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
Nanoparticles use magnetoelectricity to target and eradicate cancer cells
John Michael Bryant, Emmanuel Stimphil, Victoria Andre, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 3, 2025
Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine Models
John Michael Bryant, Max Shotbolt, Emmanuel Stimphil, et al.
Immunity
|
April 16, 2020
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling
Eslam Mohamed, Rosa A Sierra, Jimena Trillo-Tinoco, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2022
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma
Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, et al.
Frontiers in Immunology
|
December 3, 2025
Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small lymphocytic lymphoma
Lilit Karapetyan, Joel Kuriakose, Matthew C Perez, et al.
Page
of 11